Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Alicaforsen

Generic Name: Alicaforsen

Drug Type: Small Molecule

CAS Number: 185229-68-9

Unique Ingredient Identifier: J8435V445B

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in crohn's disease and ulcerative colitis.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1 Food Effect Study for Alicaforsen Tablets

Phase 1

Completed

Posted: 2018/03/22

Sponsor:Atlantic Pharmaceuti...

ID:NCT03473626

Efficacy of Alicaforsen in Pouchitis Patients Who Have Failed to Respond to at Least One Course of Antibiotics

Phase 3

Completed

Posted: 2015/08/17

Sponsor:Atlantic Pharmaceuti...

ID:NCT02525523

ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.

Phase 2

Completed

Posted: 2003/07/08

Sponsor:Ionis Pharmaceutical...

ID:NCT00063830

ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis

Phase 2

Completed

Posted: 2003/06/27

Sponsor:Ionis Pharmaceutical...

ID:NCT00063414

Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease

Phase 3

Completed

Posted: 2002/10/30

Sponsor:Ionis Pharmaceutical...

ID:NCT00048295

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy